(Q35161305)

6 August 2017

1 reference

title

Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature (English)

1 reference

6 August 2017

0 references

R Zaidan

1

1 reference

6 August 2017

M Al Moallem

2

1 reference

6 August 2017

B A Wani

3

1 reference

6 August 2017

A R Shameena

4

1 reference

6 August 2017

A R Al Tahan

5

1 reference

6 August 2017

A K Daif

6

1 reference

6 August 2017

S Al Rajeh

7

1 reference

6 August 2017

publication date

1 July 2003

1 reference

European Journal of Neurology

6 August 2017

published in

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

367-372

1 reference

Clinical uses of intravenous immunoglobulins

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Complications of intravenous immune globulin treatment in neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Intravenous immune globulin therapy for neurologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Safety of intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Central retinal vein occlusion complicating treatment with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Early Guillain-Barré syndrome without inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Human immunoglobulins inhibit thrombin-induced Ca2+ movements and nitric oxide production in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00542.X

10.1046/J.1468-1331.2003.00542.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference